BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16412558)

  • 21. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
    Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
    J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
    Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
    Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations.
    Odermatt A; Nashev LG
    J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):1-13. PubMed ID: 20100573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme.
    Schweizer RA; Zürcher M; Balazs Z; Dick B; Odermatt A
    J Biol Chem; 2004 Apr; 279(18):18415-24. PubMed ID: 14973125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane.
    Odermatt A; Arnold P; Stauffer A; Frey BM; Frey FJ
    J Biol Chem; 1999 Oct; 274(40):28762-70. PubMed ID: 10497248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
    Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
    Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity.
    Hewitt KN; Walker EA; Stewart PM
    Endocrinology; 2005 Jun; 146(6):2539-43. PubMed ID: 15774558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis.
    Liu Y; Park F; Pietrusz JL; Jia G; Singh RJ; Netzel BC; Liang M
    Physiol Genomics; 2008 Feb; 32(3):343-51. PubMed ID: 18073273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
    Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemistry and physiology of hexose-6-phosphate knockout mice.
    Zielinska AE; Walker EA; Stewart PM; Lavery GG
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):213-8. PubMed ID: 21146583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1.
    Zhou HY; Hu GX; Lian QQ; Morris D; Ge RS
    Toxicology; 2012 Feb; 292(1):1-12. PubMed ID: 22154985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of hexose-6-phosphate dehydrogenase results in reduced overall glucose consumption but does not prevent 11β-hydroxysteroid dehydrogenase-1-dependent glucocorticoid activation.
    Marbet P; Klusonova P; Birk J; Kratschmar DV; Odermatt A
    FEBS J; 2018 Nov; 285(21):3993-4004. PubMed ID: 30153376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microsomal enzyme 17β-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase.
    Legeza B; Balázs Z; Nashev LG; Odermatt A
    Endocrinology; 2013 Jan; 154(1):205-13. PubMed ID: 23183177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of lumenal orientation of microsomal 50-kDa esterase/N-deacetylase.
    Ozols J
    Biochemistry; 1998 Jul; 37(28):10336-44. PubMed ID: 9665742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
    Gong R; Morris DJ; Brem AS
    Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M; Seckl JR
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.